Eden Prairie, MN, United States of America

Emily R Rolfes Meyering

This inventor holds 10 USPTO granted patents, plus 3 CIPO patents and 4 EPO patents. Top assignees: Surmodics, Inc., Boston Scientific Scimed, Inc., Spinethera. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emily R Rolfes Meyering. Retrieved from https://idiyas.com/inventor/emily-r-rolfes-meyering

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 60.0

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 29(Granted Patents)

Location History:

Eden Prairie, MN (US) (2013 - 2017)
Minnetonka, MN (US) (2018)
Saint Louis Park, MN (US) (2017 - 2023)

Company Filing History:

Boston Scientific Scimed, Inc.

4. 1 out of 834,601

Other

patents

Years Active: 2013-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11771707 - Pharmaceutical compositions and uses thereof (2023-10-03),

2. 10925883 - Pharmaceutical compositions and uses thereof (2021-02-23),

3. 9987115 - Film encapsulated pelvic implant system and method (2018-06-05),

4. 9649405 - Fibroin-containing hydrogels for pelvic tissue treatment (2017-05-16),

5. 9539079 - Systems, methods, and implants for treating prolapse or incontinence (2017-01-10),

6. 8932694 - Fluorinated polymers and lubricious coatings (2015-01-13),

7. 8927000 - Lipid coating for medical devices delivering bioactive agent (2015-01-06),

8. 8722076 - Photochrome- or near IR dye-coupled polymeric matrices for medical articles (2014-05-13),

9. 8586731 - Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation (2013-11-19),

10. 8568760 - Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof (2013-10-29),

Title: Emily R Rolfes Meyering: Innovator in Pharmaceutical Compositions

Introduction

Emily R Rolfes Meyering is a prominent inventor based in Eden Prairie, MN (US). She has made significant contributions to the field of pharmaceutical compositions, holding a total of 10 patents. Her innovative work focuses on the development of microsphere technologies that enhance drug delivery systems.

Latest Patents

Among her latest patents, Meyering has developed pharmaceutical compositions that involve a plurality of substantially spherical microspheres. These microspheres comprise at least one active pharmaceutical ingredient (API) that is substantially dispersed in a polymer, along with a lyoprotectant on the outside surface. The microspheres are designed to have a D99 particle diameter of less than about 10 µm and a D90 circularity value ranging from about 0.8 to about 1.0. These compositions are intended for injectable applications and aim to treat various medical conditions effectively.

Career Highlights

Meyering has worked with notable companies in the pharmaceutical industry, including Surmodics, Inc. and Spinethera. Her experience in these organizations has allowed her to refine her expertise in drug formulation and delivery systems.

Collaborations

Some of her notable coworkers include Jeffrey Missling and Henry Meyer. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical sector.

Conclusion

Emily R Rolfes Meyering is a trailblazer in the field of pharmaceutical innovations, with a focus on enhancing drug delivery through her patented microsphere technologies. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.